Jump to Main ContentJump to Primary Navigation

Tamoxifen breast cancer drug move is ‘excellent’

    Jewish breast cancer campaigners have hailed as “excellent” new NHS guidelines allowing potential sufferers access to drugs that reduce the risk of developing the disease.

    The National Institute for Health and Care Excellence (Nice) issued a report this week saying that half a million British women should be offered tamoxifen or raloxifene which bring down the risk of breast cancer by 30 to 40 per cent.

    The guidelines also modify the threshold for genetic testing, making it available to more women.

    Jewish Genetics Disorder UK executive director Katrina Sarig said: “This is an excellent development. It is particularly important for Jewish people given their increased risk.”

    According to the organisation, one in 40 women of Ashkenazi ancestry carry a mutation of the BRCA gene which causes breast cancer. The figure is one in 500 carriers in the general population.

    Campaigner Emma Parlons, who had a preventative double mastectomy and ovary removal surgery, described Nice’s report as “a glimpse of the future”.

    She said: “When my surgeon told me to stop worrying about my daughter because there will probably be a drug that she can take, she was kind of right, and it’s really exciting.”

    But the 41-year-old writer was doubtful whether drugs would have sufficiently lowered her 85 per cent risk of developing breast cancer.

    She said: “If I was faced with the decision today, I would still have a double mastectomy.”

    Under the guidelines, women will be chosen on a case by case basis depending on family history and level of risk, which is heightened if more than one family member has suffered from cancer at a young age.

    Baroness Delyth Morgan, chief executive of Breast Cancer Campaign, said: “This is a truly historic moment… we are witnessing a fundamental change of clinical practice driven by medical research.”

    NICE is the first European body to recommend that healthy women be given drugs to prevent breast cancer. Concerns have been raised about potential side effects.

    Katherine Woods, research information manager at the Breast Cancer Campaign, said some women may experience “menopausal-like effects” and, in very rare cases, more severe medical problems.

    The issue of breast cancer screening hit the headlines earlier this year when Hollywood actress Angelina Jolie announced she had undergone a preventative double mastectomy after being diagnosed with a mutation of the BRCA gene.

Uk News

Strictly Orthodox Ukip candidate 'should not run for office'

Marcus Dysch

Tuesday, February 28, 2017

Strictly Orthodox Ukip candidate 'should not run for office'
Special Reports

Dublin benefits from overseas aid

Barry Toberman

Sunday, January 8, 2017

Dublin benefits from overseas aid
Uk News

Luciana Berger troll driven by 'fierce antisemitism'

JC Reporter

Monday, December 5, 2016

Luciana Berger troll driven by 'fierce antisemitism'
Uk News

Government drops pledge to aid 3,000 child refugees

Rosa Doherty

Wednesday, February 8, 2017

Government drops pledge to aid 3,000 child refugees
Uk News

Limmud: Food for thought at session on 'ethical eating'

By Simon Rocker

Tuesday, December 27, 2016

Limmud: Food for thought at session on 'ethical eating'
Uk News

Local MP blocks visit from David Irving's 'secret tour'

Rosa Doherty

Friday, December 2, 2016

Local MP blocks visit from David Irving's 'secret tour'
Uk News

Anti-Israel conference faces delay

Lee Harpin

Thursday, January 19, 2017

Anti-Israel conference faces delay
Uk News

Commission criticised over inquiry into 'antisemitic' charity

Daniel Sugarman

Monday, December 5, 2016

Commission criticised over inquiry into 'antisemitic' charity
Uk News

Fawlty Towers star Andrew Sachs dies aged 86

JC Reporter

Friday, December 2, 2016

Fawlty Towers star Andrew Sachs dies aged 86